Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Kiryukhina (Saint-Petersburg, Russian Federation), M. Dyakova (Saint-Petersburg, Russian Federation), D. Esmedlyaeva (Saint-Petersburg, Russian Federation). Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis. 4104

Member's Comments

No comment yet.

Related content which might interest you: Nitric oxide in acute testing in patients with pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Inhaled nitric oxide in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2006; 28: Suppl. 50, 399s Year: 2006 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Nitric oxide vs prostacyclin in chronic high-flow pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002 Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Nitric oxide attenuates the Th1 cells that are upregulated in patients with active pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001 Exhaled nitric oxide and pulmonary function in children with sickle cell disease Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016